More about

Type 2 Diabetes

News
May 24, 2022
2 min read
Save

Use of real-time CGM linked to lower health care costs in type 2 diabetes

Use of real-time CGM linked to lower health care costs in type 2 diabetes

The use of real-time continuous glucose monitoring is associated with a decrease in diabetes-related health care costs, according to a brief report published in Diabetes Technology & Therapeutics.

News
May 23, 2022
2 min read
Save

CGM prevents glycemic deterioration in insulin-treated adults with type 2 diabetes

CGM prevents glycemic deterioration in insulin-treated adults with type 2 diabetes

Adults with type 2 diabetes treated with insulin who initiate continuous glucose monitoring better maintain their HbA1c compared with those who do not use CGM, according to study findings.

News
May 23, 2022
2 min read
Save

Genetic risk, low diet quality increase type 2 diabetes risk

Genetic risk, low diet quality increase type 2 diabetes risk

Genetic risk and poorer diet quality each independently increase the risk for developing type 2 diabetes, according to study data.

News
May 19, 2022
2 min read
Save

More severe CKD increases risk for poor COVID-19 outcomes with type 2 diabetes

More severe CKD increases risk for poor COVID-19 outcomes with type 2 diabetes

SAN DIEGO — Adults with type 2 diabetes hospitalized with COVID-19 are more likely to be admitted to the ICU, require mechanical ventilation or die if they have more advanced chronic kidney disease, according to a speaker.

News
May 18, 2022
1 min read
Save

Top in endocrinology: Strategies to reduce burnout; new treatment for type 2 diabetes

Top in endocrinology: Strategies to reduce burnout; new treatment for type 2 diabetes

The top story in endocrinology last week focused on medical providers’ work-life balance and the use of self-care to reduce work-related burnout.

News
May 17, 2022
2 min read
Save

SGLT2 inhibitors may lower risk for adverse renal outcomes vs. DPP-IV inhibitors

SGLT2 inhibitors may lower risk for adverse renal outcomes vs. DPP-IV inhibitors

The use of SGLT2 inhibitors with type 2 diabetes is associated with lower risks for end-stage renal disease and acute renal failure compared with DPP-IV inhibitor use, according to study findings from Hong Kong.

News
May 16, 2022
2 min read
Save

Arterial stiffness better predicts diabetes risk vs. hypertension

Arterial stiffness better predicts diabetes risk vs. hypertension

Arterial stiffness better predicts type 2 diabetes risk than hypertension, with comorbid elevated BP and arterial stiffness more than doubling risk for the disease compared with those with ideal vascular function, researchers reported.

News
May 13, 2022
2 min read
Save

FDA approves tirzepatide, first dual incretin agonist for type 2 diabetes

FDA approves tirzepatide, first dual incretin agonist for type 2 diabetes

The FDA announced it approved the injectable dual incretin agonist tirzepatide to improve glucose response in adults with type 2 diabetes in addition to diet and exercise.

News
May 13, 2022
5 min watch
Save

VIDEO: AACE tailors new fatty liver guideline to endocrinologists

VIDEO: AACE tailors new fatty liver guideline to endocrinologists

SAN DIEGO — In this video exclusive, Jonathan D. Leffert, MD, talks with Kenneth Cusi, MD, FACP, FACE, about the new American Association of Clinical Endocrinology nonalcoholic fatty liver disease guideline tailored for endocrinologists.

News
May 11, 2022
2 min read
Save

Worse diabetes severity increases risk for mortality after severe hypoglycemia

Worse diabetes severity increases risk for mortality after severe hypoglycemia

Diabetes Severity Score is the only factor significantly linked to greater mortality risk among older adults with type 2 diabetes experiencing severe hypoglycemia, according to study data published in Diabetes & Vascular Disease Research.

View more